Literature DB >> 27237751

Characterizing retinal structure injury in African-Americans with multiple sclerosis.

Navid Seraji-Bozorgzad1, Sheridan Reed2, Fen Bao3, Carla Santiago4, Alexandros Tselis4, Evanthia Bernitsas4, Christina Caon2, Elliot Frohman5, M Tariq Bhatti6, Bruce A C Cree7, Omar Khan2.   

Abstract

To examine retinal structure injury in African-Americans (AA) with Multiple Sclerosis (MS) compared to Caucasians (CA) with MS, we used spectral domain optical-coherence tomography (OCT) in this cross sectional study. The peripapillary retinal nerve fiber layer (pRNFL) and macular volume of 234 MS patients (149 CA; 85 AA) and 74 healthy controls (60 CA; 17 AA) were measured. Intra-retinal segmentation was performed to obtain retinal nerve fiber (RNFL), ganglion cell (GCL), inner plexiform (IPL), inner nuclear (INL), outer plexiform (OPL), outer nuclear (ONL), retinal pigment epithelium (RPE), and photoreceptor (PR) layer volumes. Study was approved by IRB, and informed consent obtained from all participants. We found that pRNFL was thicker in AA v. CA healthy controls (100.9 vs 97.00μm, p=0.004). Compared to HC, MS patients demonstrated thinner pRNFL (p<0.0001), and lower TMV (p<0.001), macular RNFL (p<0.0001), GCL (p<0.0001), and IPL (p<0.0001). AAMS patients had thinner pRNFL (87.2 vs 90.0μm, and lower TMV (8.2 vs 8.4mm(3), p=0.0001), RNFL (0.73 vs 0.79mm(3), p=0.0001), and GCL (0.94 vs 0.98mm(3), p=0.007) than CAMS patients. Sub-analysis of patients without history of AON showed thinner pRNFL (88.9 vs 93.1µm) and TMV (8.2 vs. 8.5mm(3), p<0.0001) in AAMS compared to CAMS patients. In conclusion, this cross-sectional study provides evidence supporting greater retinal structure injury in AAMS compared to CAMS patients, irrespective of history of AON. Our findings are consistent with other studies demonstrating a more severe CNS tissue injury in AAMS patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  African-American; Health disparity; Multiple sclerosis; Optical coherence tomography; Retinal structure injury

Mesh:

Year:  2016        PMID: 27237751     DOI: 10.1016/j.msard.2016.02.009

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

Review 2.  Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.

Authors:  Annette F Okai; Annette M Howard; Mitzi J Williams; Justine D Brink; Chiayi Chen; Tamela L Stuchiner; Elizabeth Baraban; Grace Jeong; Stanley L Cohan
Journal:  Neurology       Date:  2022-04-25       Impact factor: 11.800

3.  Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis.

Authors:  Jacob Rube; Madeline Bross; Christopher Bernitsas; Melody Hackett; Fen Bao; Evanthia Bernitsas
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

4.  Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis.

Authors:  Lilyana Amezcua; Ashley H Beecham; Silvia R Delgado; Angel Chinea; Margaret Burnett; Clara Patricia Manrique; Refujia Gomez; Manuel Comabella; Xavier Montalban; Melissa Ortega; Leticia Tornes; Brett T Lund; Talat Islam; David Conti; Jorge R Oksenberg; Jacob L McCauley
Journal:  Ann Clin Transl Neurol       Date:  2018-09-23       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.